VALENCIA, Calif., Dec. 2 /PRNewswire/ -- The Alfred E. Mann Foundation for Biomedical Engineering (AEMFBE), a philanthropic organization created by billionaire Alfred E. Mann to establish university-based commercialization- enablement institutes at elite universities, designed to facilitate biomedical product development for the benefit of society, today announced the launch of a Web site (http://www.mannfbe.org).
Features of the web site include:
-- Overview of Alfred Mann Institutes for Biomedical Development (AMIs),
including the infrastructure and process that are created by the minimum of
$100 million endowment to establish each Institute. To date, three Alfred
Mann Institutes have been endowed:
-- Background and accomplishments of Mr. Mann, who has dedicated most of his career to bettering the quality of life for those who suffer from life debilitating disorders through the development of innovative medical devices.
-- "Commercialize Your Idea," which provides insight into the developmental steps for a biomedical technology including proof of concept, FDA regulatory approval, reimbursement strategies, technology licensing considerations, etc., with an emphasis toward researchers involved in this space.
"The AMI concept has drawn a phenomenal response, both nationally and internationally, as a new model for technology transfer, a form of venture philanthropy," said A. Stephen Dahms, Ph.D., President and CEO of the AEMFBE. "The Web site addresses researchers' frequently asked questions and provides an overview of the AMI selection and creation process."
|SOURCE Alfred E. Mann Foundation for Biomedical Engineering|
Copyright©2008 PR Newswire.
All rights reserved